Healthcare / Healthcare Services / Signal Release

Press Release

Healthcare Security Reaches USD 49.67 Billion by 2033 at 11.90 Per Cent — Revenue per Secure Endpoint Rises 35.7 Per Cent While the Price of the Camera Falls

· Healthcare

Pheonix Research publishes its 2026–2033 forecast for the global healthcare security systems market

20th November 2026 — The global healthcare security systems market will reach USD 49.67 billion by 2033, from USD 20.21 billion in 2025, according to a new market report published today by Pheonix Research. That is an 11.90 per cent compound annual growth rate over the 2026–2033 forecast window, or 2.46 times the 2025 base in eight years.

The number that explains the market is not the growth rate. It is the one underneath it. Installed secure endpoints — cameras, readers, access-controlled doors, screening lanes, infant-protection tags, nurse-call and duress devices — grow from 118.6 million to 214.8 million over the same period, at 7.71 per cent a year. Revenue per secure endpoint therefore rises from roughly USD 170 to USD 231, an increase of 35.7 per cent, in a market where the price of the device itself is flat to falling.

The gap between those two curves is the finding. The endpoint count grows at the rate at which hospitals build, renovate and replace estates. The revenue grows faster because a rising share of the bill is no longer equipment. It is the worksite analysis, the incident record, the commissioning file, the network map, the monitoring seat and the audit log. Hospitals buy evidence, not cameras, and the report is built on that distinction.

Six of seven requirements are documents

The strongest demand driver in this market is not a threat assessment. It is an accreditation standard. The Joint Commission’s workplace violence prevention requirements, which took effect on 1 July 2025, require hospitals to run a prevention programme under a designated leader, train staff at hire and regularly, establish policies for prevention, response, reporting, victim support and governing-body reporting, complete a worksite analysis, and analyse incident data for trends.

Six of those seven components are documents. None of them can be satisfied by a better camera. They can only be satisfied by a system that produces a written analysis, retains an incident record, and can show a surveyor what was found and what was done about it. The report treats this as the structural reason why the software and services attached to a physical security estate now carry more of the growth than the estate itself.

The proposal that would turn a camera estate into a register

The second driver is still a proposal, and the report labels it as one everywhere it appears. The HIPAA Security Rule Notice of Proposed Rulemaking issued by the US Department of Health and Human Services Office for Civil Rights on 27 December 2024 would require covered entities and business associates to develop and revise a technology asset inventory and a network map showing how electronic protected health information moves through their systems — on an ongoing basis, but at least once every 12 months, and again in response to any change in environment or operations that may affect that information.

No camera vendor sells a technology asset inventory. But a modern IP camera is an unpatched Linux host on the hospital network, and a networked access panel is operational technology in a clinical building. The security estate is frequently the largest uncontrolled endpoint population in a hospital, and it is usually the only register that already records device, location and firmware in one place. If the rule is finalised in its proposed shape, the physical security system becomes the fastest available route to a compliance artefact the hospital is obliged to produce.

The report is explicit that the mix shift does not depend on the rule surviving. Accreditation and the European Union’s NIS2 directive point in the same direction without it; the rule, if finalised, moves the timing forward rather than creating the demand.

The layer the register already belongs to grows fastest

Integrated security software grows at 15.72 per cent in this model, the fastest of the five layers, while accounting for only 7.32 per cent of 2025 market value. Managed services and maintenance grow at 13.70 per cent. Hardware — cameras, readers, panels, screening equipment — grows at 10.18 per cent. Software and services together grow at 14.20 per cent, a 4.02-point gap over hardware that is a finance fact before it is a technology fact.

Screening grows at 15.38 per cent for a clinical reason, not a threat reason

The fastest-growing hardware category is walk-through and weapons screening, at 15.38 per cent. The reason is not that hospitals expect more attacks. It is that screening has been redesigned around throughput. Baystate Health’s programme, announced on 18 September 2026, screens visitors without requiring them to empty pockets, is specified to be safe for patients with pacemakers and for pregnant visitors, and commits publicly that emergency patients will never be delayed by the lane.

Read the specification carefully and every constraint in it is a constraint on time, not on detection. That is what makes screening buyable in a building whose operational margin is 1.3 per cent: it is sold as a flow product, and its failure mode is a queue rather than a miss.

The constraint is 1.3 per cent

Kaufman Hall’s National Hospital Flash Report closed the 2025 adjusted year-to-date operating margin at 1.3 per cent. Against that number, a 4.02-point growth gap between hardware and software-plus-services is not a preference. Capital is scarce, so hospitals extend the estate they own and buy the services that make it defensible, rather than replacing it.

What breaks the forecast

The report tests three deviations against its base case and reports each one rather than asserting the base case as a point estimate:

  • Services grow at 10.00 per cent rather than 13.70 per cent — the market reaches USD 46.61 billion at 11.01 per cent. The services layer lands at USD 10.12 billion rather than USD 13.18 billion, because procurement keeps services inside capital projects and never converts them to contracts.
  • Screening reverts to the market rate of 11.90 per cent rather than 15.38 per cent — the market reaches USD 48.75 billion at 11.64 per cent, with screening at USD 3.29 billion rather than USD 4.21 billion.
  • Capital discipline caps growth at 8.00 per cent across the whole market — the market reaches USD 37.41 billion, a 24.7 per cent reduction against the 2033 base figure.

The third case is the one the report tells suppliers to plan against, because it requires no regulatory reversal and no competitive surprise. It requires only that the current financial picture continues.

Three falsifiers

A forecast that cannot be wrong is not a forecast. The report states three mechanisms that would prove it wrong.

  • A regulator writes a number. The services premium exists because specification is qualitative — a worksite analysis, a documented risk assessment, a tuned analytics configuration. If a regulator replaces qualitative specification with a pass mark — a stated detection threshold, a numeric false-alarm ceiling, a certified product list — the work becomes comparable on a price sheet and the premium compresses. The report calls this the most plausible route by which the mix shift reverses, and notes it would arrive as a well-intentioned simplification.
  • Hospital margins recover durably. The mix shift assumes capital stays scarce. A durable return to mid-single-digit operating margins makes capital requests fundable again, hospitals buy new estates rather than services attached to old ones, and hardware outgrows services. A reader who expects that recovery should treat the 8 per cent case as the central estimate, not the downside.
  • Screening fails its cost-benefit test in public. Screening is bought on the promise that it reduces harm without delaying care. One large, well-evidenced programme evaluation showing no measurable reduction in incidents against a measurable throughput cost would not stop screening — but it would stop its expansion, and the 15.38 per cent assumption goes with it.

A scope warning that applies to every figure in this category

Published figures for healthcare security systems differ by a factor of two or more, and the divergence is almost never method. It is category boundary. Definitions counting only physical security hardware produce a market less than half the size of the one modelled here. Pheonix’s scope includes managed services, screening lanes, the integration software layer and infant and patient protection, and excludes hospital cybersecurity software spend and security officer labour in full.

The 2025 base of USD 20.21 billion is therefore broader than many figures a reader will encounter. Comparability requires reconciling scope first. Where this model differs from another estimate, the first question to ask is what that estimate left out.

Method: 70 per cent secondary disclosure, 30 per cent primary research

Roughly 70 per cent of the evidence base is secondary disclosure: accreditation standards and their effective dates, the text of the proposed HIPAA Security Rule and its compliance time periods, hospital financial reporting and margin data, company filings and product literature, and public programme announcements from health systems. The remaining 30 per cent is Pheonix primary research — structured interviews with hospital security, facilities and compliance leadership, with integrators and guarding providers who carry the commissioning and service relationship, and with screening and access-control vendors; conference-floor and exhibition sessions where procurement specifications are discussed openly; and survey work on specification practice. Primary evidence is used to test what the documents imply, and where it contradicts the secondary record the report says so.

About the report

The full report, Global Healthcare Security Systems Market Report, Size, Share and Forecast 2026–2033: Hospitals Buy Evidence, Not Cameras, runs to six chapters — value chain, technology and innovation, competitive landscape, regulatory landscape, investment activity, and market risk — with tables and charts, ten profiled companies, and a full source list. It is available at the report page.

Related Pheonix research

Companies covered in the report

The report profiles ten suppliers operating across platform, services and clinical-workflow positions, each linked to its own disclosure: Johnson Controls, Honeywell International, Motorola Solutions, Bosch Security and Safety Systems, Siemens, Securitas, ADT Inc., Nedap, Ascom and Zebra Technologies.

Sources

All figures in this release are from the Pheonix Research report cited above. Values are expressed in US dollars; the market is sized on installed secure endpoints across physical security, screening, integration software and patient protection categories.